InsiderGauge
Checking updates…
Dashboard

CBIOCRESCENT BIOPHARMA, INC.

Market cap
$476.22M
as of 2026-10-23
Latest close
$12.82
as of 2026-10-23
Sector
Healthcare
as of 2026-10-24
Industry
Biotechnology
as of 2026-10-24

Cluster

No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).

Form 4 historysince 2023-10-03

InsiderTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
McNeill JonathanPresident and COOSep 18Sep 18S3,839$16.71Sale −$64,150134,588YesForm 4
Brumm Joshua TChief Executive OfficerSep 18Sep 18S7,837$16.71Sale −$130,956271,765YesForm 4
McNeill JonathanPresident and COOSep 16Sep 18S731$17.90Sale −$13,085138,427YesForm 4
Brumm Joshua TChief Executive OfficerSep 16Sep 18S1,610$17.90Sale −$28,819279,602YesForm 4
Bispham Barbara HarlinSee RemarksSep 16Sep 18S620$17.90Sale −$11,09818,710YesForm 4
Scalzo Richard WilliamChief Financial OfficerSep 16Sep 18S568$17.90Sale −$10,16719,730YesForm 4
Im Ellie EunkyungChief Medical OfficerSep 16Sep 18S623$17.90Sale −$11,15221,446YesForm 4
Pinkas JanChief Scientific OfficerSep 16Sep 18S658$17.90Sale −$11,77821,581YesForm 4
Lynch RyanSee RemarksSep 16Sep 18S240$17.90Sale −$4,29613,631YesForm 4
Fairmount Healthcare Fund II L.P.Jul 16Jul 20P853,450$14.50Purchase +$12,375,0253,601,316NoForm 4
Fairmount Healthcare Fund II L.P.Jul 16Jul 20P · derivative525,897$14.50Purchase +$7,625,5072,294,037NoForm 4
Brumm Joshua TChief Executive OfficerJun 22Jun 23S42,305$17.99Sale −$761,067281,212YesForm 4
McNeill JonathanPresident and COOJun 22Jun 23S20,549$17.99Sale −$369,677139,158YesForm 4
Im Ellie EunkyungChief Medical OfficerJun 22Jun 23S1,219$17.99Sale −$21,93022,069YesForm 4
Bispham Barbara HarlinSee RemarksJun 22Jun 23S1,218$17.99Sale −$21,91219,330YesForm 4
Scalzo Richard WilliamChief Financial OfficerJun 22Jun 23S1,112$17.99Sale −$20,00520,298YesForm 4
Pinkas JanChief Scientific OfficerJun 22Jun 23S1,288$17.99Sale −$23,17122,239YesForm 4
Lynch RyanSee RemarksJun 22Jun 23S465$17.99Sale −$8,36513,871YesForm 4
Harwin Peter EvanJun 2Jun 3A · derivative11,050$17.01$187,96111,050NoForm 4
Moran SusanJun 2Jun 3A · derivative11,050$17.01$187,96111,050NoForm 4
Balcom AlexandraJun 2Jun 3A · derivative11,050$17.01$187,96111,050NoForm 4
Lubner David CharlesJun 2Jun 3A · derivative11,050$17.01$187,96111,050NoForm 4
Violin JonathanJun 2Jun 3A · derivative11,050$17.01$187,96111,050NoForm 4
Bispham Barbara HarlinSee RemarksDec 15, 2025Dec 17, 2025A12,422not reportednot reported12,422NoForm 4
Bispham Barbara HarlinSee RemarksDec 15, 2025Dec 17, 2025A6,000not reportednot reported18,422NoForm 4
Bispham Barbara HarlinSee RemarksDec 15, 2025Dec 17, 2025A · derivative72,185$13.21$953,56472,185NoForm 4
Lynch RyanSee RemarksDec 15, 2025Dec 17, 2025A8,378not reportednot reported8,378NoForm 4
Lynch RyanSee RemarksDec 15, 2025Dec 17, 2025A4,000not reportednot reported12,378NoForm 4
Lynch RyanSee RemarksDec 15, 2025Dec 17, 2025A · derivative33,512$13.21$442,69433,512NoForm 4
Im Ellie EunkyungChief Medical OfficerDec 15, 2025Dec 17, 2025A16,298not reportednot reported16,298NoForm 4
Im Ellie EunkyungChief Medical OfficerDec 15, 2025Dec 17, 2025A5,000not reportednot reported21,298NoForm 4
Im Ellie EunkyungChief Medical OfficerDec 15, 2025Dec 17, 2025A · derivative65,190$13.21$861,16065,190NoForm 4
McNeill JonathanPresident and COODec 15, 2025Dec 17, 2025A19,507not reportednot reported153,707NoForm 4
McNeill JonathanPresident and COODec 15, 2025Dec 17, 2025A6,000not reportednot reported159,707NoForm 4
McNeill JonathanPresident and COODec 15, 2025Dec 17, 2025A · derivative78,029$13.21$1,030,76378,029NoForm 4
Scalzo Richard WilliamChief Financial OfficerDec 15, 2025Dec 17, 2025A14,422not reportednot reported14,422NoForm 4
Scalzo Richard WilliamChief Financial OfficerDec 15, 2025Dec 17, 2025A5,000not reportednot reported19,422NoForm 4
Scalzo Richard WilliamChief Financial OfficerDec 15, 2025Dec 17, 2025A · derivative57,688$13.21$762,05857,688NoForm 4
Brumm Joshua TChief Executive OfficerDec 15, 2025Dec 17, 2025A45,117not reportednot reported313,517NoForm 4
Brumm Joshua TChief Executive OfficerDec 15, 2025Dec 17, 2025A10,000not reportednot reported323,517NoForm 4
Brumm Joshua TChief Executive OfficerDec 15, 2025Dec 17, 2025A · derivative180,467$13.21$2,383,969180,467NoForm 4
Doughty Christopher GrantChief Business OfficerDec 15, 2025Dec 17, 2025A14,714not reportednot reported54,194NoForm 4
Doughty Christopher GrantChief Business OfficerDec 15, 2025Dec 17, 2025A8,000not reportednot reported62,194NoForm 4
Doughty Christopher GrantChief Business OfficerDec 15, 2025Dec 17, 2025A · derivative58,855$13.21$777,47558,855NoForm 4
Pinkas JanChief Scientific OfficerDec 15, 2025Dec 17, 2025A17,507not reportednot reported17,507NoForm 4
Pinkas JanChief Scientific OfficerDec 15, 2025Dec 17, 2025A5,000not reportednot reported22,507NoForm 4
Pinkas JanChief Scientific OfficerDec 15, 2025Dec 17, 2025A · derivative70,025$13.21$925,03070,025NoForm 4
Brumm Joshua TChief Executive OfficerDec 8, 2025Dec 10, 2025A · derivative345,672$13.17$4,552,500345,672NoForm 4
McNeill JonathanPresident and COODec 8, 2025Dec 10, 2025A · derivative172,836$13.17$2,276,250172,836NoForm 4
Harwin Peter EvanDec 4, 2025Dec 8, 2025P1,360,000$13.41Purchase +$18,237,6002,747,866NoForm 4
Harwin Peter EvanDec 4, 2025Dec 8, 2025P · derivative131,434$13.41Purchase +$1,762,5301,768,140NoForm 4
Pinkas JanChief Scientific OfficerJul 16, 2025Jul 16, 2025A · derivative142,474$13.14$1,872,108142,474NoForm 4
Lubner David CharlesJun 23, 2025Jun 23, 2025A · derivative9,023$15.30$138,0529,023NoForm 4
Balcom AlexandraJun 23, 2025Jun 23, 2025A · derivative9,023$15.30$138,0529,023NoForm 4
Violin JonathanJun 23, 2025Jun 23, 2025A · derivative9,023$15.30$138,0529,023NoForm 4
Harwin Peter EvanJun 23, 2025Jun 23, 2025A · derivative9,023$15.30$138,0529,023NoForm 4
Moran SusanJun 23, 2025Jun 23, 2025A · derivative9,023$15.30$138,0529,023NoForm 4
Bvf Gp Holdings LLCJun 13, 2025Jun 17, 2025J657,308not reportednot reported707,116NoForm 4
Bvf Gp Holdings LLCJun 13, 2025Jun 17, 2025J556,617not reportednot reported593,740NoForm 4
Bvf Gp Holdings LLCJun 13, 2025Jun 17, 2025J56,079not reportednot reported62,383NoForm 4
Bvf Gp Holdings LLCJun 13, 2025Jun 17, 2025J · derivative304,098not reportednot reported304,098NoForm 4
Bvf Gp Holdings LLCJun 13, 2025Jun 17, 2025J · derivative257,515not reportednot reported257,515NoForm 4
Bvf Gp Holdings LLCJun 13, 2025Jun 17, 2025J · derivative25,944not reportednot reported25,944NoForm 4
Siren, L.L.C.Aug 8, 2024Aug 9, 2024S260,873$0.19Sale −$49,5666,317,565NoForm 4
Siren, L.L.C.Aug 7, 2024Aug 9, 2024S61,488$0.18Sale −$11,0686,578,438NoForm 4
Invus Public Equities Advisors, LLCAug 6, 2024Aug 7, 2024S55,732$0.18Sale −$10,0326,639,926NoForm 4
Invus Public Equities Advisors, LLCAug 5, 2024Aug 7, 2024S164,523$0.19Sale −$31,2596,695,658NoForm 4
Siren, L.L.C.Aug 2, 2024Aug 5, 2024S286,200$0.20Sale −$57,2406,860,181NoForm 4
Siren, L.L.C.Aug 1, 2024Aug 5, 2024S63,564$0.22Sale −$13,9847,146,381NoForm 4
Siren, L.L.C.Jul 30, 2024Jul 30, 2024S756,835$0.22Sale −$166,5047,209,945NoForm 4
Siren, L.L.C.Jul 29, 2024Jul 30, 2024S363,949$0.24Sale −$87,3487,966,780NoForm 4
Siren, L.L.C.Jul 26, 2024Jul 30, 2024S258,335$0.24Sale −$62,0008,330,729NoForm 4
Rock EdwinChief Medical OfficerJun 21, 2024Jun 24, 2024P115,000$0.27Purchase +$31,050680,403NoForm 4
Rock EdwinChief Medical OfficerJun 20, 2024Jun 24, 2024P190,000$0.25Purchase +$47,500565,403NoForm 4
Hahn Brian M.SVP Finance, CFOJun 18, 2024Jun 20, 2024P17,500$0.25Purchase +$4,37570,643NoForm 4
Junius Daniel MMay 1, 2024May 1, 2024A · derivative40,000$1.62$64,80040,000NoForm 4
Jackson Scott ThomasMay 1, 2024May 1, 2024A · derivative40,000$1.62$64,80040,000NoForm 4
Andrews Patricia SMay 1, 2024May 1, 2024A · derivative40,000$1.62$64,80040,000NoForm 4
King Rachel K.May 1, 2024May 1, 2024A · derivative40,000$1.62$64,80040,000NoForm 4
Pearson Timothy RMay 1, 2024May 1, 2024A · derivative40,000$1.62$64,80040,000NoForm 4
Goldberg Mark AlanMay 1, 2024May 1, 2024A · derivative40,000$1.62$64,80040,000NoForm 4
Koenig ScottMay 1, 2024May 1, 2024A · derivative40,000$1.62$64,80040,000NoForm 4
King Rachel K.Mar 29, 2024Apr 2, 2024A3,334$3.00$10,002515,194NoForm 4
Goldberg Mark AlanMar 29, 2024Apr 2, 2024A4,584$3.00$13,75224,828NoForm 4
Junius Daniel MMar 29, 2024Apr 2, 2024A5,209$3.00$15,62798,459NoForm 4
Hahn Brian M.SVP Finance, CFOJan 12, 2024Jan 17, 2024A · derivative250,000$3.11$777,500250,000NoForm 4
Rath ChinmayaSVP and Chief Business OfficerJan 12, 2024Jan 17, 2024A · derivative250,000$3.11$777,500250,000NoForm 4
Rock EdwinChief Medical OfficerJan 12, 2024Jan 17, 2024A · derivative250,000$3.11$777,500250,000NoForm 4
Semerjian HaroutChief Executive OfficerJan 12, 2024Jan 17, 2024A · derivative695,000$3.11$2,161,450695,000NoForm 4
Johnson Bruce SSVP & Chief Commercial OfficerJan 12, 2024Jan 17, 2024A · derivative250,000$3.11$777,500250,000NoForm 4
Goldberg Mark AlanDec 29, 2023Jan 2, 2024A5,827$2.36$13,75220,244NoForm 4
King Rachel K.Dec 29, 2023Jan 2, 2024A4,238$2.36$10,002511,860NoForm 4
Andrews Patricia SDec 29, 2023Jan 2, 2024A5,191$2.36$12,25158,608NoForm 4
King Rachel K.Sep 30, 2023Oct 3, 2023A6,667$1.50$10,001507,622NoForm 4
Andrews Patricia SSep 30, 2023Oct 3, 2023A8,167$1.50$12,25153,417NoForm 4
Goldberg Mark AlanSep 30, 2023Oct 3, 2023A9,167$1.50$13,75114,417NoForm 4